NEWS RELEASE
CLEVELAND CLINIC AND THE HEBREW UNIVERSITY OF JERUSALEM TO DEVELOP GLOBAL CENTER FOR TRANSFORMATIVE NANOMEDICINE
Center to Revolutionize Delivery of Novel Diagnostics and Treatments for Major Medical Challenges Worldwide
October 12, 2015, Cleveland, Ohio, USA – Jerusalem, Israel – Cleveland Clinic and The Hebrew University of Jerusalem will begin a formal initiative to raise funds and develop a virtual global Center for Transformative Nanomedicine. This partnership will harness the power of nanoscience and nanotechnology with the goal of revolutionizing the delivery of new therapies and treatments worldwide.
This major new collaboration will advance research and create a dynamic exchange of knowledge, especially in the areas of cardiovascular disease, neurological disease and cancer, all of which afflict millions worldwide. In partnership, these leading institutions will blaze new paths in the emerging field of nanotechnology, using nanoparticles invisible to the naked eye to create novel drug delivery systems and unique medical technologies with lifesaving potential.
“Our two institutions will leverage resources and begin to combine our scientific knowledge,” says Professor Menahem Ben-Sasson, President, The Hebrew University of Jerusalem. “These powerful interactions will expedite better medical treatments, more rapid, cost-effective diagnostics, and improved healthcare delivery for people the world over.”
Nanotechnology enables doctors to deliver medications to select sites, preventing drugs from degrading in the body before reaching targeted sites because the miniscule particles are protected. A potentially transformative new dimension of medicine, this remarkably precise technology allows delivery of large doses of drugs to be released at a specific site and only to that site, causing fewer side effects than many traditional treatments. Customized and carefully calibrated drug treatment offers the possibility of greater effectiveness and patient safety. In addition, nanotechnology is used to create inexpensive devices that facilitate therapy and new ways of diagnosing disease. This technology also promises to save money and time. Often, doctors can run tests in their office rather than send samples to a laboratory.
“We are honored to join with Hebrew University to advance the emerging field of nanotechnology,” said Toby Cosgrove, M.D., President and CEO of Cleveland Clinic. “The new Center for Transformative Nanomedicine will ensure development of novel therapeutics to improve longevity, enhance patient well-being, make medical care more cost-effective, and provide dynamic solutions to global health concerns.”
The Center for Transformative Nanomedicine will strive to translate scientific discoveries into practical applications that could be instrumental in preventing, diagnosing and treating illness. Cleveland Clinic and The Hebrew University of Jerusalem are renowned for propelling innovation in the field of medicine. Cleveland Clinic is a leader nationally and internationally in laboratory-based, translational and clinical research, as well as exceptional patient care.
The Hebrew University of Jerusalem is Israel’s top-ranked university and among the top 100 worldwide, achieving success in biotechnology, nanotechnology, molecular modeling and drug development. In Israel, Hebrew University is affiliated with five hospitals and commercializes many of its medical and pharmaceutical innovations. By establishing the Center for Transformative Medicine, these notable institutions combine their respective strengths and interdisciplinary capabilities to advance medical knowledge and improve patient care for future generations.
The two leading institutions announced a five-year commitment to raising $15 million-plus in first-stage funding to establish the virtual center, which will foster interdisciplinary research at the Hebrew University’s Faculty of Medicine and School of Pharmacy, its Faculty of Science and the Harvey M. Krueger Family Center for Nanoscience and Nanotechnology, in combination with Cleveland Clinic’s Department of Biomedical Engineering, part of Cleveland Clinic’s Lerner Research Institute.
“The Hebrew University’s Harvey M. Krueger Center for Nanoscience and Nanotechnology and the Institute for Drug Research at the School of Pharmacy in the Faculty of Medicine have the sophisticated facilities, research infrastructure and scientific expertise to complement Cleveland Clinic’s efforts in many aspects of medicine,” said Professor Isaiah (Shy) Arkin, Hebrew University Vice President of Research. “Likewise, Cleveland Clinic is known for its advanced methods of exploring, testing and applying new technologies in a clinical setting. Each institution has a successful track record in commercializing technology.”
Joint fundraising efforts through the current Cleveland Clinic “The Power of Every One” campaign and American Friends of The Hebrew University (AFHU), a national nonprofit organization that raises support for Hebrew University in the U.S., will be conducted to develop this pioneering center. The center will have an administrative director position and scientific advisory board and offer training and educational opportunities; a consortium to pursue drug delivery applications; and a research conference in 2016/2017, through which investigators can seek collaborators to develop joint projects and proposals in translational research and engage in efforts to find appropriate external funding to support the consortium. Collaborative research proposals will be developed, based on the work of combined teams of investigators.
D. Geoffrey Vince, Ph.D., chair of Biomedical Engineering at Cleveland Clinic’s Lerner Research Institute, and Professor Simon Benita, former Head of the Institute for Drug Research and the School of Pharmacy at Hebrew University’s Faculty of Medicine, will lead the efforts to develop the global Center for Transformative Nanomedicine.
Editor’s Note: A video overview with interviews and laboratory footage is available at http://dial.ccf.org/session/40b830da0616d63ed127d38515ba7b63/Nanotechnology%20Announcement%20Full%20Video.wmv. For one-minute B-roll footage, click on one of the following formats: .wmv file, .mov file, or .mp4 file.
About The Hebrew University of Jerusalem and Nanomedicine
The Hebrew University of Jerusalem is Israel’s foremost institution of higher learning and research, with seven academic facilities located on four campuses. It is ranked among the top-100 worldwide. Founded in 1918, The Hebrew University educates approximately 23,000 students annually and engages in many international academic and research partnerships with institutions throughout the world. Within the Faculty of Science, The Harvey M. Krueger Family Center for Nanoscience and Nanotechnology facilitates scientific interactions across multiple disciplines and develops new uses for nanotechnology. The Unit for Nanoscopic Characterization and the Unit for Nanofabrication in the Krueger Center’s multi-user research infrastructure promotes neuroscience and nanotechnology. Research covers diverse fields including new materials, molecular and nano-electronics, nanomedicine, nanopharmacy and nanobiology. One especially important area is directed drug delivery, conducted in collaboration with Hebrew University’s School of Pharmacy at the Faculty of Medicine and its Silberman Institute for Life Sciences at the Faculty of Science. The School of Pharmacy is renowned for the development of nanomedicines and the development of nano-based drug delivery systems. Much of this work is commercialized through Yissum, the technology transfer arm of The Hebrew University. To learn more, please visit www.huji.ac.il.
About American Friends of The Hebrew University
American Friends of The Hebrew University (AFHU), is a national, nonprofit organization whose mission is to promote awareness of, and raise support for, The Hebrew University of Jerusalem in the United States. AFHU events, programs and missions in communities throughout the United States, help to ensure that The Hebrew University is a research engine for the world and an engine of growth for the State of Israel. To learn more about The Hebrew University and its groundbreaking nanomedical partnership with Cleveland Clinic, please visit www.afhu.org.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, USA, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic Health System includes a main campus near downtown Cleveland, eight community hospitals, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, and Cleveland Clinic Florida and the Lou Ruvo Center for Brain Health in Las Vegas, Nevada, USA, Cleveland Clinic Canada in Toronto, and Cleveland Clinic Abu Dhabi, UAE. In 2013, there were 5.5 million outpatient visits throughout the Cleveland Clinic Health System and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at www.clevelandclinic.org. Follow us at www.twitter.com/ClevelandClinic.